Atlas Trials

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Clinical trial NCT02007356 · RECRUITING

Trial details

NCT number
NCT02007356
Sponsor
University Hospital, Basel, Switzerland
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Adenovirus InfectionEBVCytomegalovirus InfectionsCytokine Capture SystemAllogenic Disease
Start date
2014-12-01
Primary completion
2026-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.